US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust NYSE Arca Biotechnology Index Fund

266.44

+0.65000.24%

Post-market: 266.440.00000.00%19:30 EDT

Volume:51.13K

Turnover:13.62M

Market Cap:2.92B

PE:31.18

High:267.47

Open:267.37

Low:265.26

Close:265.79

52wk High:275.23

52wk Low:182.08

Shares:10.95M

Float Shares:10.95M

Volume Ratio:0.23

T/O Rate:0.47%

Dividend:- -

Dividend Rate:- -

EPS(TTM):8.55

EPS(LYR):37.75

ROE:19.96%

ROA:-0.16%

PB:1.05

PE(LYR):7.06

Loading ...

Overview Company News Filings

Alkermes Announces Positive Phase 1B Results Demonstrating Clinical Proof-of-Concept for Alks 7290 in Adults with Attention-Deficit Hyperactivity Disorder (Adhd)

THOMSON REUTERS

Alkermes - Phase 2 Study of Alks 7290 in Adults with Adhd Enrolling, Data Expected in 2027

THOMSON REUTERS

Corcept President, Oncology Roberto Wandenkolk Vieira Sells 296 Shares for $29,842.72

Alkermes Files Form 3 for Director Anne Clem Whitaker`

Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)

Corcept Says EU CHMP Backs Lifyorli Combo for Platinum-Resistant Ovarian Cancer

Corcept Therapeutics Incorporated - Ec to Issue Final Approval Decision in Q4 2026

THOMSON REUTERS

Corcept Announces Chmp Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)

THOMSON REUTERS

FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Twist Bioscience (TWST) and Medpace Holdings (MEDP)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Veracyte (VCYT), IQVIA Holdings (IQV) and Chemed (CHE)

Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial

Corcept Director James N. Wilson Disposes of $1.11 Million in Common Shares

Bruker Nano Exec VP Mark Munch Sells 2,000 Bruker Shares for $105,740

Veracyte Director Jens Holstein Disposes of USD 204,747 Common Shares

Alkermes Appoints Anne Whitaker to Board of Directors

Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors

THOMSON REUTERS

Brookfield Strikes $2.9 Billion Cash Deal for Australian Plumbing Supplier Reliance Worldwide

Fourth Bid Succeeds: Brookfield Clinches $2.9 Billion Deal for Australian Pipe Maker RWC at 32% Premium

Veracyte Adds Another Stream to Bladder Franchise, UBS Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/FBT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","market":"US","secType":"STK","nameCN":"First Trust NYSE Arca Biotechnology Index Fund","latestPrice":266.44,"timestamp":1790971200000,"preClose":265.79,"halted":0,"volume":51129,"hourTrading":{"tag":"盘后","latestPrice":266.44,"preClose":266.44,"latestTime":"19:30 EDT","volume":18,"amount":4793.6848,"timestamp":1790983804969,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.002445539711802465,"floatShares":10950002,"shares":10950002,"eps":8.545272,"marketStatus":"Market Closed","change":0.65,"latestTime":"10-02 16:00:00 EDT","open":267.37,"high":267.465,"low":265.2589,"amount":13615858.23858,"amplitude":0.0083,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.545272,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":265.79,"sharesOutstanding":11450002,"nav":265.84,"aum":2897656531.68,"bidAskSpread":0.000914,"preHourTrading":{"tag":"盘前","latestPrice":265.84,"preClose":265.79,"latestTime":"07:07 EDT","volume":21,"amount":5569.2,"timestamp":1790939266223,"change":0.05,"changeRate":0.000188,"amplitude":0.008428},"postHourTrading":{"tag":"盘后","latestPrice":266.44,"preClose":266.44,"latestTime":"19:30 EDT","volume":18,"amount":4793.6848,"timestamp":1790983804969,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.23051848500740743,"impliedVol":0.2223,"impliedVolPercentile":0.6972},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBT\",,,,,undefined,":{"symbol":"FBT","floatShares":10950002,"roa":"-0.16%","roe":"19.96%","lyrEps":37.754725,"volumeRatio":0.23051848500740743,"shares":10950002,"dividePrice":0,"high":267.465,"amplitude":0.0083,"preClose":265.79,"low":265.2589,"week52Low":182.08,"pbRate":"1.05","psRate":"703.82","week52High":275.23,"institutionHeld":0,"latestPrice":266.44,"eps":8.545272,"divideRate":0,"volume":51129,"delay":0,"ttmEps":8.545272,"open":267.37,"prevYearClose":206.52,"prevWeekClose":272.86,"prevMonthClose":272.26,"prevQuarterClose":272.26,"fiveDayClose":272.86,"twentyDayClose":273.79,"sixtyDayClose":256.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBT\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FBT","amount":1.1726,"announcedDate":"2024-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust NYSE Arca Biotechnology Index Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"market":"US","date":"2022-01-10","symbol":"FBT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1641790800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-12-30","symbol":"FBT","amount":2.2136,"defaultRemindTime":1640874600000,"name":"First Trust NYSE Arca Biotechnology Index Fund","recordDate":"2022-01-10","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBT\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-10","value":2.2136,"currency":"USD"},{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":1.1726,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669150548","title":"Alkermes Announces Positive Phase 1B Results Demonstrating Clinical Proof-of-Concept for Alks 7290 in Adults with Attention-Deficit Hyperactivity Disorder (Adhd)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150548?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA9RZ6JR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","MEDX","PSCH","IBRN","PSIL","ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150512","title":"Alkermes - Phase 2 Study of Alks 7290 in Adults with Adhd Enrolling, Data Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150512","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150512?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA9RZ6JR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","PSIL","ALKS","PSCH","FBT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668358979","title":"Corcept President, Oncology Roberto Wandenkolk Vieira Sells 296 Shares for $29,842.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2668358979","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668358979?lang=en_us&edition=fundamental","pubTime":"2026-09-19 07:54","pubTimestamp":1789775650,"startTime":"0","endTime":"0","summary":"Corcept President, Oncology Roberto Wandenkolk Vieira sells 296 shares for $29,842.72Corcept’s President, Oncology Roberto Wandenkolk Vieira sold 296 common shares on Sep. 16, 2026 at $100.82.He repor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL5zJb0H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept President, Oncology Roberto Wandenkolk Vieira Sells 296 Shares for $29,842.72","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0566484027.USD","LU1559883803.SGD","CORT","BK4007","FBT","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668789973","title":"Alkermes Files Form 3 for Director Anne Clem Whitaker`","url":"https://stock-news.laohu8.com/highlight/detail?id=2668789973","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668789973?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:48","pubTimestamp":1789764537,"startTime":"0","endTime":"0","summary":"Alkermes files Form 3 for director Anne Clem Whitaker`Alkermes director Anne Clem Whitaker filed a Form 3 initial statement of beneficial ownership dated Sept. 14, 2026.Disclaimer:This news brief was ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL7wyxYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRN","PSIL","ALKS","MEDX","PSCH","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668273689","title":"Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668273689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668273689?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:30","pubTimestamp":1789749010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corcept Therapeutics (CORT) and Xenon (XENE) with bu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corcept-therapeutics-cort-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corcept-therapeutics-cort-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRN","LU0029874061.USD","XLV","BK4585","XBI","LU0128526141.USD","LU1559883803.SGD","BK4532","SBIO","BK4007","FBT","BK4581","LABU","LU0566484027.USD","PSCH","BK4137","HCSG","CORT","BK4139","BK4588","XENE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668923679","title":"Corcept Says EU CHMP Backs Lifyorli Combo for Platinum-Resistant Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2668923679","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668923679?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:01","pubTimestamp":1789732903,"startTime":"0","endTime":"0","summary":"Corcept says EU CHMP backs Lifyorli combo for platinum-resistant ovarian cancerEU drug regulator’s CHMP backed marketing authorization for Corcept’s Lifyorli (relacorilant) with nab-paclitaxel in plat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDLcd4Vr8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","FBT","LU0566484027.USD","CORT","BK4532","PSCH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668923688","title":"Corcept Therapeutics Incorporated - Ec to Issue Final Approval Decision in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2668923688","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668923688?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:00","pubTimestamp":1789732800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA4Q98SD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4532","PSCH","CORT","BK4007","LU1559883803.SGD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668923684","title":"Corcept Announces Chmp Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668923684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668923684?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:00","pubTimestamp":1789732800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA4Q98SD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSCH","LU0566484027.USD","LU1559883803.SGD","FBT","BK4007","CORT","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668991067","title":"FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A","url":"https://stock-news.laohu8.com/highlight/detail?id=2668991067","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668991067?lang=en_us&edition=fundamental","pubTime":"2026-09-18 02:35","pubTimestamp":1789670130,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration approved Fayuvi, which it calls “the first treatment for pediatric patients with mucopolysaccharidosis type I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-ultragenyx-gene-therapy-for-sanfilippo-syndrome-type-a-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","IBB","IBBQ","SYNB","FBT","BK4588","TBXU","CNCR","BK4585","GNOM","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996274","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Twist Bioscience (TWST) and Medpace Holdings (MEDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996274?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648219,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alkermes (ALKS), Twist Bioscience (TWST) and Medpa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-twist-bioscience-twst-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-twist-bioscience-twst-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065169927.USD","WDNA","FBT","LABU","TWST","LU0128526141.USD","IBRN","XBI","ALKS","LU2065170008.USD","BK4585","BK4139","PSIL","HCSG","PSCH","BK4581","IDNA","LU2065171311.SGD","ARKG","XLV","GNOM","BK4137","BK4588","MEDX","MEDP","LU2065171402.SGD","BK4121","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668115964","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Veracyte (VCYT), IQVIA Holdings (IQV) and Chemed (CHE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668115964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668115964?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:50","pubTimestamp":1789645810,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Veracyte (VCYT), IQVIA Holdings (IQV) and Chemed (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-veracyte-vcyt-iqvia-holdings-iqv-and-chemed-che-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-veracyte-vcyt-iqvia-holdings-iqv-and-chemed-che-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0130102774.USD","LU0477156797.USD","LU1543694498.USD","LU2413665964.HKD","LU0128526141.USD","XLV","HEAL","LABU","FBT","HCSG","LU0648001328.SGD","BK4585","LU1165135440.EUR","LU1620156213.USD","LU2413666004.HKD","IE00BLDYK493.USD","LU0882574055.USD","BK4139","BK4121","LU0130103400.USD","LU1261432733.SGD","LU1596574779.USD","LU0528227936.USD","LU0648000940.SGD","LU0130518102.USD","CHE","LU0130517989.USD","BK4137","LU1989764748.USD","LU1791710400.SGD","LU1201861249.SGD","BK4581","LU1791710582.SGD","XBI","EKG","LU0477156953.USD","BK4588","LU0980610538.SGD","LU1201861165.SGD","IQV","LU1989764664.SGD","LU1620156130.USD","BK4530","LU0198837287.USD","BK4196","LU1721427968.SGD","LU0029874061.USD","IE00B64QTZ34.USD","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668936994","title":"Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668936994","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668936994?lang=en_us&edition=fundamental","pubTime":"2026-09-17 05:35","pubTimestamp":1789594520,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced topline results from ELPIS II, its Phase 2b clinical trial evaluating its investigational stem cell therapy laromestroc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","BK4585","TBXU","BK4139","GNOM","IBB","BK4588","HYLG","LGVN","FBT","MEDX","CNCR","SYNB","GDOC","LFSC","IBBQ","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668693589","title":"Corcept Director James N. Wilson Disposes of $1.11 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2668693589","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668693589?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:31","pubTimestamp":1789590707,"startTime":"0","endTime":"0","summary":"Corcept director James N. Wilson disposes of $1.11 million in common sharesCorcept director James N. Wilson reported selling 10,000 common shares on Sept. 15, 2026.Sales prices ranged from USD 110.27 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL5LXKps:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Director James N. Wilson Disposes of $1.11 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CORT","FBT","LU1559883803.SGD","BK4532","PSCH","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668933265","title":"Bruker Nano Exec VP Mark Munch Sells 2,000 Bruker Shares for $105,740","url":"https://stock-news.laohu8.com/highlight/detail?id=2668933265","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668933265?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:16","pubTimestamp":1789589780,"startTime":"0","endTime":"0","summary":"Bruker Nano Exec VP Mark Munch sells 2,000 Bruker shares for $105,740Mark Munch, executive vice president and president of Bruker Nano, sold 2,000 Bruker common shares at USD 52.87 on Sep. 15, 2026.He","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL78KKS2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bruker Nano Exec VP Mark Munch Sells 2,000 Bruker Shares for $105,740","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRKR","FBT","BK4121","TINY","LU0757428866.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668393317","title":"Veracyte Director Jens Holstein Disposes of USD 204,747 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2668393317","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668393317?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:09","pubTimestamp":1789589347,"startTime":"0","endTime":"0","summary":"Veracyte director Jens Holstein disposes of USD 204,747 common sharesVeracyte director Jens Holstein sold 5,000 common shares on Sept. 14, 2026 at a weighted average price of $40.95.Holdings fell to 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL3rcYDf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Veracyte Director Jens Holstein Disposes of USD 204,747 Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607455","title":"Alkermes Appoints Anne Whitaker to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607455","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607455?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556448,"startTime":"0","endTime":"0","summary":"Alkermes appoints Anne Whitaker to board of directorsAlkermes appointed Anne C. Whitaker as an independent director to its board.Whitaker is a biopharmaceutical executive with commercial, operational,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL86gXCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","PSIL","BK4139","IBRN","FBT","PSCH","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607123","title":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607123?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA78XSXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","PSIL","ALKS","PSCH","FBT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117818184","title":"Brookfield Strikes $2.9 Billion Cash Deal for Australian Plumbing Supplier Reliance Worldwide","url":"https://stock-news.laohu8.com/highlight/detail?id=1117818184","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117818184?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:40","pubTimestamp":1789555227,"startTime":"0","endTime":"0","summary":"Brookfield Asset Management has sealed an all-cash acquisition agreement for Reliance Worldwide, valuing the plumbing fittings manufacturer at an enterprise worth of $2.9 billion. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU0757428866.USD","LU1815336091.USD","FBT","TINY","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161539100","title":"Fourth Bid Succeeds: Brookfield Clinches $2.9 Billion Deal for Australian Pipe Maker RWC at 32% Premium","url":"https://stock-news.laohu8.com/highlight/detail?id=1161539100","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161539100?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:34","pubTimestamp":1789526059,"startTime":"0","endTime":"0","summary":"Brookfield Asset Management has reached an agreement to acquire Reliance Worldwide Corp. in an all-cash transaction that values the Australian piping products manufacturer at roughly A$4.1 billion...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","BK4121","LU0757428866.USD","LU1815336091.USD","BRKR","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667162504","title":"Veracyte Adds Another Stream to Bladder Franchise, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667162504","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667162504?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:58","pubTimestamp":1789487931,"startTime":"0","endTime":"0","summary":"Veracyte  is adding an adjacent product to its bladder franchise following its acquisition of Convergent Genomics, UBS Securities said in a Monday note.\"We view this as a strategic move by VCYT to expand menu ofofferings into urine-based monitoring,\" the note said.Late Monday, the company reported the Convergent acquisition for $150 million upfront, plus up to $30 million in milestone payments tied to reimbursement.The deal adds Convergent's UroAmp urinary tumor DNA platform, the note said, adding that it has been clinically validated in non-muscle invasive bladder cancer for therapy-response monitoring and post-treatment surveillance.\"While revenue contribution is likely a few years away, the addition of UroAmp reinforces our Buy rating and our view that VCYT has multiple growth levers capable of supporting long-duration double-digit revenue growth,\" the report said.Price: 41.18, Change: -0.03, Percent Change: -0.07","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FBT","VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}